Jala, Pika J.
HRN: 27-74-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2025
METRONIDAZOLE 500MG (TAB)
09/02/2025
09/06/2025
PO
500mg
BID
H Pylori
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines